Clinical Trial Update: Investigating if Interferon-Beta Can be Used in Patients With MS After They Have Developed Neutralizing Antibodies [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial completed evaluating whether interferon-beta can be used in patients with relapsing-remitting multiple sclerosis after developing neutr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Relapsing-remitting Multiple Sclerosis

Drugs mentioned

• Interferon-beta (interferon beta)

Snippet

Sponsor: Biogen | Conditions: Relapsing-Remitting Multiple Sclerosis | Phase 4 | Status: COMPLETED